Grupo FEDERACION BALEAR DE

• As per Data Bridge Market Research Analysis the global non-thermal processing market size was valued at USD 2.55 billion in 2025 and is expected to reach USD 4.46 billion by 2033, at a CAGR of 7.25% during the forecast period

• The market growth is largely fueled by the increasing demand for minimally processed and clean-label food products, as consumers prioritize natural taste, nutritional value, and extended shelf life without the use of heat or chemical preservatives

• Furthermore, rising concerns regarding food safety, microbial contamination, and the need for energy-efficient processing solutions are establishing non-thermal technologies as a preferred alternative to conventional thermal methods. These converging factors are accelerating the adoption of advanced processing techniques, thereby significantly boosting the industry's growth

The Cork Flooring Market was valued at USD 74.64 million in 2025 and is projected to reach USD 113.26 million by 2033, growing at a CAGR of 5.35% from 2026 to 2033. The market is witnessing steady growth driven by increasing demand for sustainable and eco-friendly flooring solutions, rising adoption of renewable building materials in residential and commercial construction, and growing awareness of indoor environmental quality and acoustic comfort.

The expanding preference for cork flooring is supported by its natural properties such as thermal insulation, sound absorption, durability, and resilience, making it suitable for both residential and commercial interiors. Increasing green building initiatives, stricter environmental regulations promoting low-emission construction materials, and rising investments in sustainable infrastructure development are further accelerating market growth globally. In addition, growing renovation activities in developed economies and increasing consumer shift toward aesthetically appealing and environmentally responsible flooring solutions are strengthening market adoption across various end-use sectors.

Did you know that early treatment of Giant Cell Arteritis (GCA) can help reduce the risk of serious complications, including vision loss? 👁️

Giant Cell Arteritis Drugs play a vital role in controlling inflammation, relieving symptoms, and helping protect blood vessels from long-term damage. With advances in medicine, patients today have more treatment options than ever before, improving disease management and quality of life.

📖 History/Origin

Giant Cell Arteritis, also known as temporal arteritis, was first recognized as a distinct inflammatory disease in the early 20th century. For decades, corticosteroids remained the primary treatment because of their ability to rapidly reduce inflammation and prevent complications. More recently, advances in immunology have led to the development of targeted biologic therapies that help manage the disease by acting on specific parts of the immune system. Today, treatment is personalized based on disease severity, patient response, and ongoing medical evaluation, with the goal…

Did you know that microscopic particles can help treat certain medical conditions without the need for major surgery? 🌟

Embolization Particles are specialized medical devices used in minimally invasive procedures to block or reduce blood flow to targeted areas. They are widely used in interventional radiology to treat conditions such as tumors, uterine fibroids, vascular malformations, and uncontrolled bleeding, offering patients effective treatment with shorter recovery times.

📖 History/Origin

The concept of embolization was introduced in the 1970s as interventional radiology emerged as a less invasive alternative to traditional surgery. Early embolization procedures used simple materials to block blood vessels, but advancements in biomaterials and imaging technology led to the development of highly specialized embolization particles with improved precision and safety. Today, embolization is a well-established treatment option performed under image guidance in hospitals and specialty medical centers worldwide, helping physicians manage a wide range of vascular and oncological conditions.